Brand · NIH DSLD
Enzymedica magnesium labels
Enzymedica files 2 on-market magnesium labels; the magnesium salt is not named in the filed record for any of them, so the compound mass cannot be computed.
Composition across the portfolio · as filed
What Enzymedica puts in the capsule besides magnesium
- 2 labels use a cellulose-based shell.
Label declarations · as filed
What Enzymedica claims on its labels
Filed declarations across this brand's labels: 5 distinct filed entries across 2 NIH DSLD labels, counted 2026-09-13; these are manufacturer statements.
- Vegan — on 2 of 2 labels
- Vegetarian — on 2 of 2 labels
- Adult (18 - 50 Years) — on 2 of 2 labels
- Gluten Free — on 2 of 2 labels
- Dairy Free — on 2 of 2 labels
What is not known · as of 2026-09-13
Gaps in the record for Enzymedica
- 2 of 2 labels do not name the magnesium salt in the filed record, so no compound mass can be computed for them.
- 2 of 2 labels have no US retail listing matched as of 2026-09-13. That is a matching gap on our side, not evidence of unavailability.
Labels 2
| Magnesium MotionNIH DSLD · Label 296550 · Capsule | form not mapped yet | 350 mg | 60 | 21.00 g | Not tracked yet |
| Magnesium MotionNIH DSLD · Label 296551 · Capsule | form not mapped yet | 350 mg | 120 | 42.00 g | Not tracked yet |
Forms filed
Compare within a form
These labels file no magnesium form text (form not mapped yet).
See all brands, all labels, or the priced form tables.
Filed composition facets
3 published excipient facets occur across 2 labels from Enzymedica in the NIH DSLD records, counted 2026-09-13.
FDA recall records for this firm
The FDA enforcement database holds 2 recall records naming Enzymedica (queried 2026-09-13); 0 of them concern a magnesium product.
These are exact brand-string matches in the recalling-firm field or product description, including other products. A name match does not establish that two similarly named firms are the same legal entity. The recalling firm and recalled product are shown in each row.
| Report date | Class | Product described by FDA | Reason for recall | Status | openFDA record |
|---|---|---|---|---|---|
| 2013-12-25 | Class II | Bulk 9835 ENZYMEDICA DIGESTBASICK capsules, packaged in poly bags in corrugated boxes (for domestic distribution) or fiber drums (for international distribution) (SKU 92085). Recalling firm: National Enzyme Co. Description does not name a magnesium product. | Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol | Terminated | F-0769-2014 |
| 2013-12-25 | Class II | Bulk 9809 ENZYMEDICA CARBGESTKOSH capsules, packaged in poly bags in corrugated boxes (for domestic distribution) or fiber drums (for international distribution) (SKU 92103). Recalling firm: National Enzyme Co. Description does not name a magnesium product. | Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol | Terminated | F-0768-2014 |
FDA assigns 3 recall classes by the assessed hazard, using the FDA classification definitions, checked 2026-09-13:
- Class I: Exposure to or use of the violating product carries a reasonable probability of serious harm to health or death.
- Class II: Exposure or use may produce temporary or medically reversible harm; the probability of serious harm is remote.
- Class III: Adverse health consequences from exposure or use are unlikely.
The FDA adverse event reporting system (CAERS) holds 6 reports naming Enzymedica as of 2026-09-13. This is a count of submitted reports across all the firm's products; it is not an incidence rate and implies no causation.
The metric
What EC100 measures
EC100 = container price ÷ (elemental mg per serving × servings per container ÷ 100)
It normalizes the declared elemental amount to a 100 mg unit. It does not score ingredients, quality, or outcomes.